20-F: Stratasys Reports 2025 Revenue Dip Amid Restructuring

Stratasys Ltd. reported a 3.7% revenue decrease in 2025, alongside a reduced net loss and increased cash reserves following a strategic restructuring and a $120 million PIPE investment.

Summary

• Total consolidated revenues in 2025 were $551.1 million, a decrease of 3.7% compared to $572.4 million in 2024.
• Products revenues decreased by $11.6 million (3.0%) to $380.3 million, mainly due to longer sales cycles.
• Services revenues decreased by $9.7 million (5.4%) to $170.8 million, primarily due to decreased systems revenues and lower Stratasys Direct Manufacturing (SDM) revenues from divestitures.
• Operating expenses decreased by $42.7 million (12.5%) to $299.8 million, driven by a $41.1 million reduction in employee-related and other costs from restructuring, and $9.1 million lower charges related to revaluation and sale of investments.
• Net loss amounted to $104.3 million ($1.28 per share) in 2025, an improvement from $120.3 million ($1.70 per share) in 2024.
• Cash, cash equivalents, restricted cash, and short-term deposits increased by $93.8 million to $245.4 million as of December 31, 2025, primarily due to a $120 million PIPE investment and $15.1 million cash from operating activities.
• The company completed a $120 million PIPE transaction with Fortissimo Capital in April 2025, issuing 11,650,485 ordinary shares at a price of $10.30 per share.
• A strategic restructuring plan, announced in August 2024, included an approximate 15% headcount reduction and a focus on high-growth potential products, materials, and software solutions, aiming for $40 million in annual run rate savings.
• Equity investment in Ultimaker was fully impaired as of December 31, 2025, with a $33.9 million impairment charge.
• Acquired key assets and operations of Forward AM Technologies GmbH in May 2025, enhancing SAF and DLP portfolios, and acquired IP portfolio and high-speed resin 3D printers from Nexa3D in June 2025.
• Launched the iAM Marketplace in October 2025, an independent, hardware-agnostic platform for additive manufacturing materials and services.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed report. While revenue declined due to external macroeconomic factors, the company demonstrated strong cost control, improved its net loss, and significantly bolstered its cash position through a strategic capital raise. The ongoing strategic acquisitions and focus on high-growth segments indicate a proactive approach to future growth despite current market headwinds.

Positives

• Net loss decreased to $104.3 million in 2025 from $120.3 million in 2024, indicating improved financial performance.
• Operating expenses decreased by 12.5% ($42.7 million) due to restructuring initiatives and cost controls.
• Cash, cash equivalents, restricted cash, and short-term deposits increased by $93.8 million to $245.4 million, significantly strengthening liquidity.
• Successful completion of a $120 million PIPE transaction with Fortissimo Capital, increasing available capital for inorganic opportunities.
• Strategic restructuring plan expected to generate $40 million in annual run rate savings and improve profitability.
• Acquisitions of Forward AM assets and Nexa3D IP/assets enhance product portfolio and IP, particularly in SAF, DLP, and high-speed resin 3D printing.
• Launch of iAM Marketplace strengthens the materials ecosystem and market position.
• Strong balance sheet with no debt, positioning the company to manage macroeconomic challenges.
• Continued investment in strategic long-term initiatives and new product introduction (NPI) programs.
• Goodwill impairment assessment showed fair value exceeded carrying amount by 5% for the Stratasys-Core reporting unit.
• The company holds approximately 2,700 granted and pending additive technology patents.
• Maintained EcoVadis Silver rating in 2025, placing the company in the top 15% of assessed companies globally for sustainability.
• Expanded ISO 14001 and ISO 45001 certifications to EMEA headquarters, SMACS manufacturing site, and new ARCH headquarters.
• SAF ReLife Solution continued to scale, supporting material reuse and waste reduction.

Negatives

• Total consolidated revenues decreased by 3.7% ($21.4 million) in 2025 compared to 2024.
• Products revenues decreased by 3.0% ($11.6 million), mainly due to longer sales cycles and macroeconomic pressure on customer capital expenditure budgets.
• Services revenues decreased by 5.4% ($9.7 million), linked to decreased systems revenues and divestiture of several SDM businesses.
• Gross profit decreased by 11.5% to $227.3 million, and total gross margin decreased to 41.2% from 44.9%.
• Gross margin from products revenues decreased to 45.7% from 49.5%, impacted by lower revenues, unfavorable product mix, higher restructuring charges ($5.8 million), and higher U.S. tariff costs ($4.4 million).
• Gross margin from services revenues decreased to 31.3% from 34.7%, due to lower services revenues and $1.2 million higher U.S. tariff costs.
• Equity investment in Ultimaker was fully impaired, resulting in a $33.9 million impairment charge in 2025, contributing to the net loss.
• The market price of ordinary shares experienced a significant decline over time, reaching all-time lows in 2024 before a slow recovery.
• Uncertainty regarding when capital spending in the 3D printing industry will recover.
• Ongoing macroeconomic headwinds, including moderately high interest rates, lingering inflation, and tight credit conditions, continue to reduce customer capital expenditure budgets.
• Geopolitical developments (Israel-Iran conflict, Israel-Hamas war) pose potential adverse impacts on operations, although currently immaterial.
• Increased import tariffs (reimposed in the U.S. by executive order) are expected to further increase prices for finished goods in 2026, adversely affecting gross margins.
• The company does not anticipate paying any cash dividends in the foreseeable future.

Risks

• Failure to introduce new or improved products and solutions that gain market share.
• Fluctuations in annual and quarterly operating results and financial condition due to various factors, including global economic developments.
• Demand for products and services, or the 3D printing market generally, may not grow as expected.
• Adverse macroeconomic trends (inflation, high interest rates, tight credit) may continue to reduce customer capital expenditure budgets.
• Declines in product/service prices or sales volume, combined with an inflexible cost structure, may adversely affect financial results.
• Restructuring actions may not yield short-term revenue increases.
• Other companies developing/marketing consumables for use in Stratasys systems could adversely affect revenues and profits.
• Shift in product mix towards lower-margin products or increased revenue from AM services business could reduce profitability.
• Intense competition and new technologies may reduce market share, especially if competitors combine.
• Future impairments of goodwill, other intangible assets, or equity investments could result in significant charges against earnings.
• Failure to successfully consummate or integrate acquisitions/investments, or realize expected performance from them.
• Inability to attract and retain key management, directors, or other key employees, especially in competitive markets like Israel and Minnesota.
• Defects in new products or enhancements could lead to product returns, liability claims, and reputational damage, especially with medical device classifications.
• Greater potential for liability claims from sales of end-use parts/systems in aerospace, medical, dental, and automotive industries.
• Significant delays or obstacles in realizing success of product offerings, particularly in medical/dental markets due to strict regulatory requirements.
• Termination or disruption of relationships with suppliers (especially single-source suppliers like Ricoh for PolyJet printer heads) or manufacturing arrangements.
• Discontinuation of operations at manufacturing sites could prevent timely order fulfillment and lead to unforeseen costs.
• Loss of, or reduction in revenues from, a significant number of resellers and independent sales agents.
• Global interruptions and delays in supply chain and distribution network (e.g., Houthis attacks in Red Sea-Suez Canal).
• Business model reliant on recurring revenue from consumables and service contracts may be adversely affected if usage rates decline or industry evolves.
• Import tariffs and retaliatory responses could increase costs and reduce demand.
• Potential hostile actions by shareholders (e.g., unsolicited tender offers, attempts to replace directors) could impact shareholder investment and strain cash resources.
• Significant cybersecurity disruptions or data breaches could adversely affect business.
• Ownership/long-term leases of manufacturing/office facilities may limit operational flexibility and incur unforeseen charges if relocated.
• Default in payment by one or more resellers or customers with large account receivable balances.
• Ongoing or future litigation could have a significant adverse effect on financial condition or profitability.
• Inability to enforce non-compete covenants, allowing competitors to benefit from former employees' expertise.
• Conditions in Israel (wars, political/economic instability) may adversely affect operations, despite current immaterial impact.
• Exchange rate fluctuations (U.S. dollar vs. NIS, Euro, Yen) may negatively affect operating results.
• Loss or reduction of Israeli government tax benefits (Approved Enterprise, Beneficiary Enterprise, Preferred Technology Enterprise) could increase income tax rate and costs.
• Terms of Israeli governmental grants may restrict manufacturing products and transferring technologies outside of Israel.
• Difficulty in enforcing U.S. judgments against the company and its officers/directors in Israel.
• Market price of ordinary shares may fluctuate regardless of operating results, leading to substantial losses.
• Low share price could hinder capital raises or value-adding acquisitions, and make the company vulnerable to hostile takeovers.
• Risks associated with the share repurchase program (reduced public float, volatility, suspension).
• No anticipated cash dividends in the foreseeable future.
• Changes to foreign private issuer status or reduced leniencies could increase compliance costs.
• Classification as a Passive Foreign Investment Company (PFIC) could lead to adverse tax consequences for U.S. shareholders.

Future Outlook

The company expects revenues to grow sequentially in 2026, assuming inflationary pressures ease and the global economy remains relatively stable, leading to shorter sales cycles. It plans to continue investing in new product introduction (NPI) programs and may deploy available capital towards potential value-enhancing, inorganic opportunities in the 3D printing industry. The company anticipates increased import tariffs in 2026 due to a new U.S. executive order, which could adversely affect gross margins, but does not foresee a significant change in raw materials or wage inflation materially impacting the business. Pillar Two taxation is not expected to have a material impact on the effective tax rate or consolidated financial statements in the foreseeable future. The company also plans to consolidate its Kiryat-Gat production site activities into its SMACS site in Eden Prairie during H2 2026 to improve efficiency and reduce costs.

Management Comments

• "We believe that following the implementation of our restructuring plan, we remain well-positioned to withstand the current adverse macro-economic trends, given our balance sheet (primarily due to our cash reserves and lack of debt) and our emphasis on operational efficiencies and execution."
• "We continue to monitor the situation, assessing further implications for our operations, supply chain, liquidity, cash flow and customer orders, in an effort to mitigate potential new adverse consequences should they arise."
• "We believe that we are well suited to continue to manage the current global macro-economic climate with a strong balance sheet and no debt, while focusing on cost controls and cash generation."
• "We have continued to selectively apply certain cost controls, while ensuring that our new product introduction, or NPI, programs are well-funded, and we plan to continue investing as needed in order to support our new product development programs."
• "Now that we have completed the PIPE with Fortissimo, we may consider deploying our available capital towards potential value-enhancing, inorganic opportunities in the 3D printing industry."
• "We estimate that those conditions have impacted us most notably by extending the length of our sales cycles and thereby reducing our products revenues."
• "Assuming that those inflationary pressures ease, and the global economy remains relatively stable, we expect that products revenues will once again improve, as and when we execute on our growth plans and as a result of shorter sales cycles."
• "We believe that our relationship with our employees is good."

Industry Context

StockSavvy.ai notes that Stratasys's strategic focus on polymer-based 3D printing and expansion into mass production parts aligns with the broader industry trend of additive manufacturing moving beyond prototyping into end-use part production. The acquisitions of Origin, RPS, Xaar 3D, Covestro's AM materials, Forward AM, and Nexa3D's IP demonstrate a clear strategy to consolidate and innovate within the polymer segment, addressing the "substantially larger total addressable market" for manufacturing solutions. The emphasis on a comprehensive ecosystem (printers, materials, software, services) and deep application engineering expertise positions Stratasys to capitalize on the increasing adoption of 3D printing in critical industries like aerospace, medical, and automotive, where precision and reliability are paramount. The launch of the iAM Marketplace also reflects an industry shift towards open materials ecosystems and certified solutions to accelerate adoption.

Comparison to Industry Standards

• Stratasys's FDM printers have exceeded 35,000 installed units, indicating significant market penetration.
• The J8 Series printers can print eight different materials simultaneously with over 500,000 color shades and textures, including Pantone Validated colors, offering superior multi-material and multi-color capabilities compared to many competitors.
• The J850 Digital Anatomy printer, with GelMatrix, TissueMatrix, and BoneMatrix resins, creates over 100 unique digital materials for medical models, achieving "true-to-life feel and response," which is a specialized capability in the medical 3D printing sector.
• The Origin Two printer offers "injection molding precision, unavailable with other resin 3D printers," suggesting a competitive edge in accuracy and consistency for production parts.
• SAF technology in H Series printers provides "uniform thermal experience" for printed parts, a significant improvement over traditional powder-bed fusion processes for consistency.
• The Neo line of stereolithography systems is highlighted for "superior surface quality, accuracy, and detail" and an "open choice of resins," differentiating it from some closed-system competitors.
• The company's approximately 2,700 granted and pending additive technology patents indicate a strong intellectual property portfolio, a key competitive advantage in the rapidly evolving 3D printing industry.
• The network of over 140 resellers and value-added channel partners is described as "the strongest and most experienced in the industry," suggesting a broader and deeper market reach than many competitors.
• Airbus printed over 25,000 flight-ready parts on Stratasys systems in 2025, bringing the total to over 200,000, demonstrating significant adoption in the demanding aerospace industry.
• General Motors and TE Connectivity are using Stratasys systems for production, indicating successful penetration into large-scale industrial manufacturing.
• The U.S. Navy leveraged Stratasys printers in seven different sites globally for experimentation, showcasing robust military adoption.

Management Changes

Corporate Governance

Legal Proceedings

• Litigation with Nano Dimension regarding Stratasys Rights Plan and Nano Dimension's tender offer: Nano's claim was dismissed without prejudice on July 1, 2024. The Israeli court expressed a preliminary view that rights plans are permissible but require board justification.
• Claims against Bambu Lab in U.S. federal district court in Texas alleging patent infringement, with a trial date of June 2026.
• Challenges to registered IP brought by competitors and other third parties in patent tribunals (e.g., European Patent Office, US Patent Trial & Appeal Board).
• The company is a party to various other legal proceedings incident to its business, but none are believed to have a significant effect on financial condition, profitability, or cash flows.

Related Party Transactions

• Investment and Distribution Agreements with Tritone Technologies Ltd. on November 13, 2025: Stratasys invested $7.0 million in Tritone for a minority interest (5,115,837 preferred A shares). Entered into an exclusive distribution agreement for Tritone's ceramic and metal-based additive manufacturing solutions worldwide. Fortissimo Capital Fund IV, L.P. (an affiliate of major shareholder Fortissimo) is a co-investor in Tritone, holding 65.15% of Tritone's issued share capital on a fully diluted basis. Stratasys appointed a representative to Tritone's board and received customary minority protection rights.
• PIPE transaction with FF6-SSYS, Limited Partnership (an affiliate of Fortissimo Capital) on April 8, 2025, for $120 million, resulting in Fortissimo becoming a major shareholder with approximately 15.5% ownership.
• Yuval Cohen, founding and managing partner of Fortissimo Capital, was appointed as a director in April 2025.

Stakeholder Impact

• Shareholders: Experienced dilution from the PIPE transaction, face potential share price volatility, no anticipated cash dividends, and are subject to influence from major shareholders and risks from hostile takeover attempts. U.S. shareholders face potential adverse tax consequences if classified as a PFIC.
• Employees: Subject to a 15% workforce reduction as part of restructuring, but benefit from continued investment in development, inclusion, wellbeing, and expanded health and safety certifications. Face risk of attrition due to decreased share price impacting RSU value and potential limitations on non-competition agreement enforceability.
• Customers: Experience longer sales cycles due to macroeconomic pressures but benefit from enhanced product offerings, expanded materials portfolio, improved customer support, and sustainability initiatives. Medical device classification of certain materials introduces new regulatory requirements.
• Suppliers: Face risks from reliance on single or limited-source suppliers and potential supply chain disruptions. Benefit from enhanced supplier sustainability governance.
• Creditors: Benefit from the company's strong balance sheet with no debt and increased liquidity from the PIPE transaction. The company has obligations under purchase orders ($93.6 million due 2026) and potential contingent payments ($66.6 million).

Next Steps

• Continue investing in new product introduction (NPI) programs.
• Deploy available capital towards potential value-enhancing, inorganic opportunities in the 3D printing industry.
• Consolidate Kiryat-Gat production site activities into the SMACS site in Eden Prairie during H2 2026 to improve efficiency and reduce costs.
• Monitor macroeconomic conditions, including inflation, interest rates, and supply chain, to mitigate adverse consequences.
• Continue to develop SAF materials internally as a result of the Covestro Additive Manufacturing acquisition.
• Expand the countries and products certified as medical devices in the coming years.
• Trial date for claims against Bambu Lab is set for June 2026.
• Annual review for foreign private issuer status as of June 30, 2026.
• Assess the impact of new U.S. executive order on tariffs on operations and financial statements, including ability to recover incremental tariffs paid.

Key Dates

Recommendation

Stratasys is navigating a challenging macroeconomic environment with declining revenues in 2025, particularly in products and services, indicating continued market headwinds. However, the company has proactively implemented a significant restructuring plan, which has led to a notable reduction in operating expenses and an improved net loss. The $120 million PIPE investment has substantially strengthened the company's liquidity and balance sheet, providing capital for strategic inorganic growth opportunities. While the full impairment of the Ultimaker investment is a negative, the overall strategic direction, including acquisitions to bolster its polymer 3D printing portfolio and the launch of the iAM Marketplace, suggests a focused effort to capture future market share. Given the mixed financial performance (revenue decline vs. improved profitability and strong cash position) and ongoing strategic adjustments, a "Hold" recommendation is appropriate. Investors should monitor the effectiveness of the restructuring, the impact of new acquisitions on revenue growth, and the recovery of the broader 3D printing market.

Keywords

3D printing, Additive Manufacturing, Polymers, FDM, PolyJet, SAF, P3, Stereolithography, Consumables, Software, GrabCAD, Stratasys Direct Manufacturing, Fortissimo Capital, Nexa3D, Forward AM, Ultimaker, SEC filing, Financial results, Restructuring, Capital raise, Macroeconomic conditions, Israel, Tariffs, Intellectual Property